Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly.
Jorga, K M
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly. [electronic resource] - Clinical pharmacology and therapeutics Sep 1997 - 300-10 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0009-9236
10.1016/S0009-9236(97)90033-3 doi
Administration, Oral
Aged
Analysis of Variance
Antiparkinson Agents--adverse effects
Benzophenones--adverse effects
Catechol O-Methyltransferase Inhibitors
Dopamine Agents--administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Drug Interactions
Enzyme Inhibitors--adverse effects
Erythrocytes--drug effects
Female
Gastrointestinal Diseases--chemically induced
Humans
Levodopa--administration & dosage
Male
Middle Aged
Nervous System Diseases--chemically induced
Nitrophenols
Tolcapone
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly. [electronic resource] - Clinical pharmacology and therapeutics Sep 1997 - 300-10 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0009-9236
10.1016/S0009-9236(97)90033-3 doi
Administration, Oral
Aged
Analysis of Variance
Antiparkinson Agents--adverse effects
Benzophenones--adverse effects
Catechol O-Methyltransferase Inhibitors
Dopamine Agents--administration & dosage
Dose-Response Relationship, Drug
Double-Blind Method
Drug Interactions
Enzyme Inhibitors--adverse effects
Erythrocytes--drug effects
Female
Gastrointestinal Diseases--chemically induced
Humans
Levodopa--administration & dosage
Male
Middle Aged
Nervous System Diseases--chemically induced
Nitrophenols
Tolcapone